D-Lung: An Analytics Platform for Lung Cancer Based on Deep Learning Technology
- Conditions
- Lung Cancer
- Registration Number
- NCT04036903
- Lead Sponsor
- Chinese University of Hong Kong
- Brief Summary
Lung cancer is one of main cause of cancer death in worldwide, characterized of low 5-year survival rate of less than 20%. Pulmonary nodule is considered as the typical imaging manifestation in early stage of lung cancer. The National Lung Screen Trial has demonstrated that the mortality rates could decline greatly, by the utility of low-dose helical computed tomography for screen of pulmonary nodules. Thus, automatic detection, diagnosis and management of pulmonary nodules, play the vital roles in computer-aided lung cancer screening and early intervention.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 130
- Subjects with suspicious lung nodules.
- Thin-layer thoracic CT and pathology examination have been performed for suspicious lung nodules.
- Subjects with accompanied lesions on CT images that may interfere to lung nodules analysis
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method accuracy 2 years proportion of true results(both true positives and true negatives) among whole instances
sensitivity 2 years true positive rate in percentage(%) derived by ROC analysis
specificity 2 years true negative rate in percentage (%) derived by ROC analysis
area under curve (AUC) 2 years area under ROC curve in percentage (%)
- Secondary Outcome Measures
Name Time Method average number of false positives per scan (FPs/scan) 2 years FPs/scan in number (N) based on free-response receiver operating characteristic (FROC) analysis
competition performance metric (CPM) 2 years Competitive performance metric (CPM) is a criterion used for CAD system evaluation. Based on FROC paradigm, CPM score is computed as an average sensitivity at seven predefined average false positive rates. CPM score ranges from 0 to 1, with higher CPM score indicating better CAD performance.
Trial Locations
- Locations (1)
The Chinese University of Hong Kong, Prince of Wale Hospital
ðŸ‡ðŸ‡°Hong Kong, Shatin, Hong Kong